Innovation in the pharmaceutical sector, specifically within antibiotics and antibody drugs, is fuelled by a multitude of factors. Increasing antimicrobial resistance necessitates the development of new antibiotics, while complex diseases like cancer and autoimmune disorders demand advanced immunotherapies. Continuous advances in technology and science also play a crucial role, alongside...
Discover more insightsIn the landscape of disease detection and health management, there is growing recognition of the significant role played by assays in autoimmune conditions, with particular focus on the Antinuclear Antibody Test (ANAT). Analysis of the market trajectory reveals a growth trend, primed by the escalating global burden of autoimmune diseases...
Discover more insights